These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 20543103

  • 1. Francisella tularensis suppresses the proinflammatory response of endothelial cells via the endothelial protein C receptor.
    Bublitz DC, Noah CE, Benach JL, Furie MB.
    J Immunol; 2010 Jul 15; 185(2):1124-31. PubMed ID: 20543103
    [Abstract] [Full Text] [Related]

  • 2. The live vaccine strain of Francisella tularensis replicates in human and murine macrophages but induces only the human cells to secrete proinflammatory cytokines.
    Bolger CE, Forestal CA, Italo JK, Benach JL, Furie MB.
    J Leukoc Biol; 2005 Jun 15; 77(6):893-7. PubMed ID: 15758077
    [Abstract] [Full Text] [Related]

  • 3. Francisella tularensis LPS induces the production of cytokines in human monocytes and signals via Toll-like receptor 4 with much lower potency than E. coli LPS.
    Dueñas AI, Aceves M, Orduña A, Díaz R, Sánchez Crespo M, García-Rodríguez C.
    Int Immunol; 2006 May 15; 18(5):785-95. PubMed ID: 16574669
    [Abstract] [Full Text] [Related]

  • 4. Innate immune response to Francisella tularensis is mediated by TLR2 and caspase-1 activation.
    Li H, Nookala S, Bina XR, Bina JE, Re F.
    J Leukoc Biol; 2006 Oct 15; 80(4):766-73. PubMed ID: 16895974
    [Abstract] [Full Text] [Related]

  • 5. GroEL and lipopolysaccharide from Francisella tularensis live vaccine strain synergistically activate human macrophages.
    Noah CE, Malik M, Bublitz DC, Camenares D, Sellati TJ, Benach JL, Furie MB.
    Infect Immun; 2010 Apr 15; 78(4):1797-806. PubMed ID: 20123721
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Natural killer and CD8 T cells dominate the response by human peripheral blood mononuclear cells to inactivated Francisella tularensis live vaccine strain.
    Gosselin EJ, Gosselin DR, Lotz SA.
    Hum Immunol; 2005 Oct 15; 66(10):1039-49. PubMed ID: 16386645
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Nature of protective immunity to Francisella tularensis.
    Tärnvik A.
    Rev Infect Dis; 1989 Oct 15; 11(3):440-51. PubMed ID: 2665002
    [Abstract] [Full Text] [Related]

  • 10. Temporal cytokine profiling of Francisella tularensis-infected human peripheral blood mononuclear cells.
    Paranavitana C, Pittman P, Velauthapillai M, DaSilva L.
    J Microbiol Immunol Infect; 2008 Jun 15; 41(3):192-9. PubMed ID: 18629413
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Francisella tularensis selectively induces proinflammatory changes in endothelial cells.
    Forestal CA, Benach JL, Carbonara C, Italo JK, Lisinski TJ, Furie MB.
    J Immunol; 2003 Sep 01; 171(5):2563-70. PubMed ID: 12928407
    [Abstract] [Full Text] [Related]

  • 13. Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria.
    Ben Nasr A, Haithcoat J, Masterson JE, Gunn JS, Eaves-Pyles T, Klimpel GR.
    J Leukoc Biol; 2006 Oct 01; 80(4):774-86. PubMed ID: 16857732
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease.
    Green M, Choules G, Rogers D, Titball RW.
    Vaccine; 2005 Apr 08; 23(20):2680-6. PubMed ID: 15780452
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fine tuning inflammation at the front door: macrophage complement receptor 3-mediates phagocytosis and immune suppression for Francisella tularensis.
    Dai S, Rajaram MV, Curry HM, Leander R, Schlesinger LS.
    PLoS Pathog; 2013 Jan 08; 9(1):e1003114. PubMed ID: 23359218
    [Abstract] [Full Text] [Related]

  • 18. Direct and indirect impairment of human dendritic cell function by virulent Francisella tularensis Schu S4.
    Chase JC, Celli J, Bosio CM.
    Infect Immun; 2009 Jan 08; 77(1):180-95. PubMed ID: 18981246
    [Abstract] [Full Text] [Related]

  • 19. Complement Receptor 3-Mediated Inhibition of Inflammasome Priming by Ras GTPase-Activating Protein During Francisella tularensis Phagocytosis by Human Mononuclear Phagocytes.
    Hoang KV, Rajaram MVS, Curry HM, Gavrilin MA, Wewers MD, Schlesinger LS.
    Front Immunol; 2018 Jan 08; 9():561. PubMed ID: 29632532
    [Abstract] [Full Text] [Related]

  • 20. Differential expression of microRNAs in Francisella tularensis-infected human macrophages: miR-155-dependent downregulation of MyD88 inhibits the inflammatory response.
    Bandyopadhyay S, Long ME, Allen LA.
    PLoS One; 2014 Jan 08; 9(10):e109525. PubMed ID: 25295729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.